Psychiatry AtlasMedication guide · United States

Antidepressant that acts on serotonin, a brain messenger

Fluoxetine (Prozac)

Generic name
fluoxetine (as fluoxetine hydrochloride)
Brand names
Prozac
Medication class
SSRI antidepressant
Forms covered
Immediate-release oral capsules

Article updated: 2026-10-24 · Sources last checked: 2026-11-05

Medication Safety Alerts

Look-alike / sound-alike name

Show more (3)

FDA Boxed Warning

Fluoxetine immediate-release daily oral capsules.

Fluoxetine carries a boxed warning for increased suicidal thoughts and behaviors in children, adolescents and young adults taking antidepressants. Monitor patients of every age for worsening symptoms or new suicidal thinking, especially when starting treatment or changing doses.

Fluoxetine treats major depression, OCD, bulimia nervosa, and panic disorder within specific age limits. This article covers daily oral capsules; certain depressive conditions require combination treatment with olanzapine.

Prozac (original brand capsules discontinued).

What to expect: Full benefit may take 4 to 5 weeks or longer, and some conditions need a longer treatment trial.

Warning signs
Sources last checked:
2026-11-05

What is this medicine used for?

FDA-approved uses

  • Major depressive disorder — Adults and children aged 8 years and older. Acute and maintenance treatment; pediatric dosing and follow-up differ from adult care.Immediate-release oral capsules.
  • Obsessive-compulsive disorder — Adults and children aged 7 years and older. Treatment of obsessions and compulsions; this age approval does not extend to every indication.Immediate-release oral capsules.
  • Bulimia nervosa — Adults. Acute and maintenance treatment of binge-eating and vomiting behaviors in moderate to severe bulimia nervosa.Immediate-release oral capsules.
  • Panic disorder — Adults. Acute treatment with or without agoraphobia.Immediate-release oral capsules.
  • Depressive episodes associated with bipolar I disorder, only with olanzapine — Adults and children aged 10 years and older. The approval requires combination with olanzapine and its additional safety information. Fluoxetine alone is not approved for bipolar depression.Immediate-release oral capsules.
  • Treatment-resistant depression, only with olanzapine — Adults. The label defines this as major depression not responding to two adequate antidepressant trials during the current episode. Combination-specific prescribing is outside the dosing overview here.Immediate-release oral capsules.

What should I expect?

Full benefit may take 4 to 5 weeks or longer, and some conditions need a longer treatment trial. Improvement may mean fewer depressive, obsessive, panic, or binge-and-purge symptoms, depending on why it was prescribed.

Agree on a follow-up plan when treatment starts. Contact the prescriber if symptoms worsen, side effects disrupt daily life, or there is no useful improvement by the planned review; do not change the dose yourself.

How do I take it safely?

Take daily capsules as prescribed, with or without food. Dosing and age limits depend on the condition. Weekly products and combination treatment with olanzapine have separate instructions; do not construct a switch or combination yourself.

Children need growth and weight checks. Diabetes may require closer glucose monitoring, and heart-rhythm risks may call for an ECG and blood tests for body salts. Do not drive until you know how it affects you.

Do not use with an MAOI or without the label’s required separation: at least 14 days after an MAOI before fluoxetine, and at least five weeks after fluoxetine before an MAOI. A clinician must manage this, including urgent situations involving linezolid or intravenous methylene blue.

MAOIs without the required clinician-managed separation, including linezolid or intravenous methylene blue. Pimozide; thioridazine during fluoxetine use or within five weeks after stopping.

Review bipolar episodes, seizures, liver disease, diabetes, low sodium, bleeding, narrow eye angles, and heart-rhythm risk before treatment.

Other serotonergic medicines, including some opioids, triptans, lithium, buspirone and St John’s wort, can increase serotonin-syndrome risk. Aspirin, anti-inflammatory pain medicines and anticoagulants can increase bleeding risk.

CYP2D6 inhibition can raise concentrations of some tricyclic antidepressants, antipsychotics and heart-rhythm medicines. Fluoxetine’s persistence matters even after the last dose. Medicines that prolong the QT interval require particular review. Avoid duplicate fluoxetine products, and review alcohol and sedating medicines with the prescriber or pharmacist.

Pregnancy decisions should consider untreated illness as well as medication risks. Available observational data have not established an overall increase in major birth defects, but late-pregnancy exposure can be associated with newborn adaptation problems, persistent pulmonary hypertension and bleeding around delivery. Do not stop abruptly because of a pregnancy concern.

Fluoxetine and norfluoxetine enter breast milk; an exposed infant should be monitored for irritability, agitation, poor feeding or poor weight gain. The approved pediatric uses are major depression from age eight and OCD from age seven; growth and mood monitoring remain important. Older adults have greater vulnerability to low sodium and may need cautious dosing.

The label recommends gradual reduction where possible and monitoring for discontinuation symptoms, such as dizziness, irritability, sleep changes or unusual tingling. The long half-life does not remove withdrawal risk and makes some interactions last much longer than symptoms suggest.

For a missed dose, the Medication Guide advises taking it when remembered unless the next dose is nearly due; then skip it. Do not take two doses together. Ask a pharmacist if the timing is uncertain.

What side effects should I know about?

  • Digestive upset, reduced appetite and sleep disturbance.
  • Nervousness, sweating and tremor.
  • Changes in sexual interest, orgasm or ejaculation.

Tell your prescriber about effects that are persistent, troublesome, or interfere with daily life.

Which warning signs need help?

  • Fever with agitation or confusion, sweating, diarrhea, muscle rigidity or twitching, and a fast heartbeat can be serotonin syndrome. Seek urgent medical care.
  • Severe rash or swelling, seizures, marked confusion, major bleeding, fainting with palpitations, or acute painful visual changes need urgent assessment.
  • New suicidal thinking or possible mania requires prompt clinical help; immediate danger requires emergency care.

What else should I know to stay safe?

  • Do not combine with MAO inhibitors, pimozide, or thioridazine. A clinician must allow at least 14 days after an MAOI before fluoxetine, and at least five weeks after fluoxetine before an MAOI or thioridazine. Linezolid and intravenous methylene blue also require specific advice.
  • Fluoxetine can interact for weeks after stopping. Have other serotonin-affecting medicines, St John’s wort, blood thinners, aspirin, anti-inflammatory pain medicines, heart-rhythm medicines, and duplicate fluoxetine products checked. Review alcohol and sedating medicines, and avoid hazardous activity while impaired.
  • Review allergies, bipolar episodes, seizures, liver disease, diabetes, low sodium, bleeding, glaucoma, and heart-rhythm risks. Children need growth and weight checks; diabetes or cardiac risk may require additional blood tests or an ECG. Plan treatment changes with the prescriber.
  • Discuss pregnancy and breastfeeding. Later-pregnancy exposure can affect newborn adjustment or breathing and bleeding around delivery; untreated illness also matters. Breastfed infants may need monitoring of feeding, weight, and unusual irritability. Older adults are more vulnerable to low sodium.

Urgent help and crisis support · Emergency & Crisis Resources (US)

What can help day to day?

  • Fluoxetine remains in the body for a long time after the last dose. This can matter for interactions and switching even when you no longer take it each day.
  • The olanzapine combination has its own benefits and risks. Fluoxetine alone does not inherit that combination’s approval for bipolar depression.

How does it work?

Fluoxetine slows the return of serotonin, a chemical messenger, into the nerve cells that released it. This leaves more serotonin available between cells and changes how they communicate. The action is thought to contribute to its benefit, but it does not mean that depression or other symptoms can be explained by a simple shortage of serotonin.

Explore more in Brain & Science: How SSRIs Work: Sertraline.

How was this medicine developed?

The FDA first approved Prozac in 1987. Fluoxetine became an early member of the SSRI antidepressant family. Later uses included OCD, bulimia nervosa, panic disorder, and specific depression treatments with olanzapine.

How do I say the name?

Fluoxetine: floo-OX-eh-teen. Capital letters show the stressed syllable.

Sources and References

Sources support the U.S. products described here. Product instructions can differ; use the information supplied with your own medicine.

  1. DailyMed: fluoxetine immediate-release capsules
  2. Fluoxetine: patient information and pronunciation
  3. Drugs@FDA: Prozac approval history and discontinued originator products
  4. FDA: Prozac prescribing information and Medication Guide
  5. Fluoxetine: Package Insert / Prescribing Information
  6. FDA: Zoloft prescribing information and Medication Guide
  7. FDA: Lexapro prescribing information and Medication Guide
  8. NIH: What Is a Neurotransmitter?
  9. PubChem: Fluoxetine parent compound and verified 2D record
  10. ISMP List of Confused Drug Names
  11. Serotonin syndrome: MedlinePlus Medical Encyclopedia
  12. Monitoring a person during and after antidepressant switching – NHS SPS - Specialist Pharmacy Service – The first stop for professional medicines advice

Giving medicine safely to children: family guide (PDF, 3 pages)

How information is checked

Was this article helpful?

Was this article helpful?

Sends your choice, article identifier, edition and optional issue to Psychiatry Atlas. No name, email or medical details are requested. Daily network codes help prevent spam; hosting may process technical information. This is not a promise of anonymity. Privacy details.

Enable JavaScript to send feedback.

Suggest a missing topic or describe a correction. Please keep personal medical information out of website feedback.

Back to top